PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Behavioral and Brain Sciences

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Behavioral and Brain Sciences has 1 tracked paper indexed in Blossom (2011) from 2 authors, across Tobacco/Nicotine Use Disorder (TUD) and Substance Use Disorders (SUD).

Published Papers

Open Accessindividual

Drugs as instruments: A new framework for non-addictive psychoactive drug use

The paper advances Müller & Schumann’s framework that treats non-addictive psychoactive drugs as instrumental tools capable of promoting happiness, social capital and economic growth, arguing that current prohibitions are misplaced because most people underuse rather than overuse such substances. It calls for policy and research shifts to permit controlled, therapeutic and scientific use of these drugs, including their judicious use by behavioural scientists to generate hypotheses and foster empathic collaboration.

Published
November 10, 2011
Journal
Behavioral and Brain Sciences
Authors
Schumann, G., Müller, C. P.

Quick Facts

Papers Indexed
1
h-Index
183
Open Access
No
Publisher
Cambridge University Press
Country
United Kingdom
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.